Kutahya Health Sciences University
Kütahya, Merkez, 43020, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07062783
This study aims to investigate changes in the levels of biomarkers (IGF-1, FGF2, and EGF) involved in neuron development in patients diagnosed with major depression through the effects of breathing exercises and aerobic exercise, as well as to examine the levels of biomarkers (TNF-α, IL-6, and IL-1) and oxidative stress (TAS, TOS, MDA, and F2-isoprostane) that are thought to play a role in the pathophysiology of depression.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Not applicable
Kütahya, Merkez, 43020, Turkey (Türkiye)
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Volunteers participating in the study who were included in the experimental group performed breathing exercises every day for three weeks. They were taught to focus their attention on the hand on their abdominal area while breathing slowly through their nose and to increase abdominal movement while reducing chest movement. They were warned that during inspiration, as air filled their lungs, the hand on their abdomen should rise upward and the hand on their chest should not move excessively. Participants continued the training until they performed the exercise correctly. The diaphragmatic breathing exercise was performed for 10 minutes in the supine position during the first week, in the semi-sitting and/or sitting position during the second week, and in the standing position during the final week.
The ratios determined as reference values for walking training in healthy adults (reference value for women = (2.11*height) - (2.29*body weight) - (5.78*age) + 667 meters - reference value for men = (7.57*height) - (1.76*body weight) - (5.0 2*age) - 309 meters) was performed at 80% intensity for at least 30 minutes on at least 3 days a week for 3 weeks. Aerobic exercise was considered for 3 weeks to facilitate adaptation to exercise and sustainability.
Time frame: From enrollment to the end of treatment at 3 weeks
It has been reported that the interaction between oxidative stress and the immune system is important, and that activated immune inflammatory pathways can trigger oxidative stress. In our study, an ELISA test will be conducted to investigate how exercise affects the levels of oxidative stress (TAS, TOS, MDA, and F2-isoprostane) biomarkers, which play a role in the pathophysiology of depression.
Time frame: From enrollment to the end of treatment at 3 weeks
It is believed that increased production of key proinflammatory cytokines such as interleukin tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 (IL-1) and acute phase reactants plays an important role in the development of depression as a result of immune system involvement.
In our study, an ELISA test will be conducted to investigate how exercise affects the levels of inflammation (TNF-α, IL-6, IL-1) which play a role in the pathophysiology of depression.
Contact information is provided by the study sponsor or research team.
Hatice Solak, Assos. Prof
CONTACT
Vedat Kurt, Assos. Prof.
CONTACT
Kutahya Health Sciences University
Other
The Effect of Respiratory and Aerobic Exercises on Neuroprotective and Inflammation Biomarkers in Patients Diagnosed With Major Depression
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05097586
Behavior, Behavioral Symptoms
Toronto, Ontario, Canada
View Trial DetailsNCT07226011
Behavior, Behavioral Symptoms
Charleston, South Carolina, United States
View Trial DetailsNCT03973268
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial DetailsNCT07560878
Behavior, Behavioral Symptoms
Belmont, Massachusetts, United States
View Trial Details